Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genotypic Resistance Guided Therapy in the Treatment of Helicobacter Pylori Infection

NCT01725906 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01725906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01725906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genotypic Resistance Guided Therapy in the Treatment of Helicobacter Pylori Infection
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2012
Completion date
December 31, 2017
Enrollment
450 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

self efficacy